MyCBD

MyCBD is an Asia focused data and analytics organisation that focuses on 3 main areas; Hemp, Cannabis and Kratom. From building and designing regulatory blueprints, dispensary management to determining efficacy of products, MyCBD is positioning itself as a complete technical and strategy resource for natural therapeutics. Segments of services is designed for Regulatory bodies, Health Providers, and Manufacturers. MyCBD provides: - • consultancy and advisory • ENAID© a patient prescription and dispensary platform Our fundamental objective is ensuring our clients are able to provide Traceability. Combining values and practices for both ESG and natural intervention, MyCBD’s ethos is to provide holistic and sustainable solutions to those in need.